FIND evaluations of SARS-CoV-2 assays

Following open calls for expressions of interest (EOI), FIND has been conducting independent evaluations of both molecular and immunoassays for SARS-CoV-2, in collaboration with multiple partner institutions (see partner map below). The calls for partners to join the evaluations for antibody, antigen and molecular tests are now closed.

More information on the evaluation process and results for each type of test can be found via the links below. For questions relating to these evaluations, please contact our Emerging Threats team.

FIND evaluations of SARS-CoV-2 antigen diagnostics

FIND evaluations of SARS-CoV-2 antibody diagnostics

FIND evaluations of SARS-CoV-2 molecular diagnostics

Our evaluation partners

  • Bioaster
  • Boston Children’s Hospital
  • Centre hospitalier universitaure vaudois (CHUV)
  • Charité
  • Hôpitaux Universitaires de Genève (HUG)
  • IS Global (Barcelona Institute of Public Health)
  • Liverpool School of Tropical Medicine (LSTM)
  • Ospedale San Raffaele (OSR)
  • Translational Health Science and Technology Institute (THSTI)
  • Universidade do Brasil (UFRJ)
  • University of Cape Town (UCT)
  • Universidad Peruana Cayetano Heredia
  • University of the Witwatersrand Johannesburg
  • Washington University in St. Louis
  • UniversitätsKlinikum Heidelberg